NewBiotics Inc. Appoints New President

Article

SAN DIEGO, Calif-NewBiotics, Inc announced January 8, that H. Michael Shepard, will be the company's president.

Shepard will be responsible for overseeing all aspects of the company's research and development strategies, scientific and corporate collaborations, and related activities.

NewBiotics, a developer of drugs targeted against cancer and infectious disease, is privately held. The company's drugs use a "Trojan horse solution" to fight various diseases.

Shepard, who previously worked for Canji, and Genentech, helped develop the p53gene product for cancer therapy.

Recent Videos
David Angulo, MD, President and Chief Executive Officer, Fungal Disease Expert
Neatly Stacked Hospital Linen, Clean Fabric in Turquoise, White, and Blue Hues. Created by AI.  (Adobe Stock 1103251410 by HQAsset)
Valerie Cadet, PhD, a virologist, immunologist, and vaccinologist at PCOM Georgia
Vector-borne Diseases  (Adobe Stock)
Chicago’s Dental Society Midwinter Meeting  (Adobe Stock 7622055 by abricotine)
Cameron Memorial Community Hospital Series With ICT
Ambassador Deborah L. Birx, MD, senior fellow of the George W. Bush Presidential Center
Cameron Memorial Community Hospital series with ICT  (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT  (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Related Content